
CBIO vs EVO
$CBIO vs $EVO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
CBIO vs EVO: the quick read
- ·CBIO is the larger company by market cap ($554M vs $544M).
- ·CBIO has been more active on our scanner (75 vs 16 alerts in 30 days).
- ·CBIO has the smaller float (28.9M vs 342.4M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·EVO trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·CBIO draws far more of our scanner's attention, 75 unusual-volume alerts in 30 days against 16, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 2% of each other on market cap, which makes the rest of this table the interesting part.
- ·EVO pays a dividend and CBIO does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing CBIO and EVO on TheDesperateTrader.
- Is CBIO or EVO the better stock?
- "Better" depends on your goal, and these two are not alike. CBIO is the larger company by market cap ($554M vs $544M). CBIO has been more active on our scanner (75 vs 16 alerts in 30 days). CBIO has the smaller float (28.9M vs 342.4M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between CBIO and EVO?
- The differences that matter: they are similar in size ($554M vs $544M); they trade at very different share prices ($14.88 vs $1.48); CBIO sits at 33% of its 52-week range against -1% for EVO; only EVO pays a dividend; our scanner flagged CBIO 75 times in the last 30 days against 16 for EVO. Everything above is measured from the latest completed session and SEC filings.
- Which of CBIO and EVO is more active right now?
- Right now CBIO is at about 0.7x its normal volume and EVO is at about 0.3x, so CBIO is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading CBIO or EVO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.